Q32 Bio Inc. (QTTB) Earnings History
Profitable10 years of earnings data (2016–2025) · Positive TTM net income
Loading earnings history...
Q32 Bio Inc. (QTTB) Earnings Overview
As of October 3, 2026, Q32 Bio Inc. (QTTB) reported trailing twelve-month net income of $34M, reflecting +136.8% year-over-year growth. The company earned $1.66 per diluted share over the past four quarters, with a net profit margin of 55.5%.
Looking at the long-term picture, QTTB's historical earnings data spans multiple years. The company achieved its highest annual net income of $30M in fiscal 2025, representing a new all-time high.
Q32 Bio Inc. maintains industry-leading profitability with a gross margin of 100.0%, operating margin of 31.5%, and net margin of 55.5%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including AKRO (-$293M net income), IMVT (-$538M net income), ARQT ($29M net income, -4.3% margin), QTTB has comparable earnings metrics. Compare QTTB vs AKRO →
QTTB Earnings vs Peers
Earnings metrics vs comparable public companies
QTTB Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $30M | +162.5% | $17M | $2.42 | 55.5% | 31.5% |
| 2024 | -$48M | +11.2% | -$66M | $-6.58 | - | - |
| 2023 | -$54M | -25.5% | -$48M | $-4.51 | - | - |
| 2022 | -$43M | -14.0% | -$39M | $-3.59 | -643.6% | -589.8% |
| 2021 | -$38M | +70.8% | -$37M | $-3.15 | - | - |
| 2020 | -$129M | -23.8% | -$130M | $-50.46 | -4762.9% | -4821.0% |
| 2019 | -$104M | -87.0% | -$110M | $-44.41 | -6237.5% | -6599.2% |
| 2018 | -$56M | -85.3% | -$60M | $-35.04 | -1044.3% | -1126.0% |
| 2017 | -$30M | -272.7% | -$30M | $-14.42 | - | - |
| 2016 | -$8M | - | -$10M | $-3.87 | - | - |
Download Data
Export QTTB earnings history in CSV or JSON format
Free sign-in required to download data
QTTB Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
QTTB — Frequently Asked Questions
Quick answers to the most common questions about buying QTTB stock.
What is QTTB earnings per share (EPS)?
QTTB trailing twelve-month (TTM) diluted EPS is $1.66, reflecting +136.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2016 to 2025 is available in the table on this page.
What is Q32 Bio Inc.'s net income?
Q32 Bio Inc. (QTTB) trailing twelve-month net income is $34M as of 2025. Earnings grew +136.8% year-over-year.
Is QTTB profitable?
Yes, QTTB is profitable with a TTM net income of $34M and a net profit margin of +55.5%.
What is QTTB's earnings growth rate?
QTTB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2016 to 2025.
What are QTTB's profit margins?
Q32 Bio Inc. net profit margin is +55.5%, operating margin is +31.5%, and gross margin is +100.0%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +125.1%.
Is QTTB growing earnings?
Yes, QTTB earnings are accelerating — EPS growth of +136.8% exceeds the 5-year CAGR of N/A. TTM net income reached $34M. Earnings momentum is strengthening.
What was QTTB's best earnings year?
Q32 Bio Inc.'s highest annual net income on record is $30M, achieved in fiscal year 2025. Earnings history on this page spans 2016 to 2025 and includes all annual and quarterly figures.
What were QTTB's earnings last quarter?
QTTB's most recent reported quarter was Q2 2026. Net income was $-9M with diluted EPS of $-0.44. For a full breakdown of all quarters, see the quarterly earnings table on this page.